Ventas Earnings Reports

Ventas delivered strong financial performance in the fourth quarter of 2024, with SHOP portfolio experiencing double-digit growth and the completion of over $2 billion in accretive investments focused on senior housing. The company's Net Debt-to-Further Adjusted EBITDA improved, and the quarterly dividend was increased by 7% due to strong results and a positive outlook.

Ventas reported strong Q3 2024 results, driven by senior housing growth. The company saw a 15.3% year-over-year growth in SHOP Same-Store Cash NOI, led by occupancy gains. Ventas has closed or placed under contract $1.7 billion of senior housing investments year to date and updated full year guidance.

Ventas reported a strong second quarter in 2024, driven by growth in the senior housing operating portfolio (SHOP). The company's financial strength has improved due to profitable organic growth in SHOP, external investments focused on senior housing, and performance throughout the portfolio. Ventas has updated and improved its full-year guidance as a result of its performance.

Ventas reported its Q1 2024 results, showing a net loss per share of ($0.04) but a Normalized FFO per share of $0.78, which is a 5% increase year-over-year. The company saw 8.2% year-over-year growth in Total Company Net Operating Income (NOI) and 6.7% growth in Total Company Same-Store Cash NOI. SHOP grew more than 15% year-over-year led by the U.S. which grew approximately 18% year-over-year.

Ventas reported strong growth in Q4 2023, driven by property performance, especially in the senior housing operating portfolio (SHOP) and outpatient medical & research portfolio. The company anticipates unprecedented demand for senior housing in the coming years due to the growing senior population.

Ventas delivered a strong third quarter with SHOP leading the way, demonstrating outstanding occupancy increases across all geographies and product types. The company updated the outlook for Attributable Net Income and Nareit FFO per share and increased the midpoint of its Normalized FFO per share guidance for the full year.

Ventas reported strong second quarter results with broad-based organic property growth across its diverse portfolio. All businesses contributed positively to total company performance, and the company demonstrated the significant competitive advantage of its scale and access to attractively priced capital.

Ventas reported solid first-quarter results, driven by SHOP and medical office buildings growth. The company reaffirmed its Normalized FFO guidance for the full year and remains focused on financial strength and flexibility. Ventas completed its plan to take ownership of the Santerre Portfolio and continues to focus on maximizing the value of the assets.

Ventas reported a net loss attributable to common stockholders of ($0.11) per share for Q4 2022. However, the company saw a year-over-year total company NOI growth of 7.5%. Same-store cash NOI grew by 8.5%, with SHOP leading the growth at 19.1%.

Ventas reported a net income attributable to common stockholders per share of $0.00 and Normalized FFO per share of $0.76 for Q3 2022. The company's SHOP segment saw a 13% year-over-year increase in same-store cash NOI, contributing to a total company same-store cash NOI growth of 4.8%.

Ventas delivered strong results in Q2 2022, driven by attractive year-over-year top and bottom-line growth in its SHOP portfolio. The company's performance benefited from strong demand and expanding pricing power, offsetting anticipated expense growth caused by broad inflationary pressures. Ventas continues to find compelling investment opportunities, with $1.3 billion of investment activity year to date.

Ventas reported Net Income per share of $0.10 and Normalized FFO per share of $0.79 for the first quarter of 2022. Total Company year-over-year same-store cash NOI grew by 5.8%, and the SHOP segment saw a 14.2% increase, driven by a nearly 10% rise in same-store revenue.

Ventas reported fourth-quarter results ahead of expectations, driven by execution amid COVID-19 waves. The company positioned itself to capture upside in senior housing recovery, delivered organic growth in Office and healthcare triple-net, and invested $3.7 billion in senior housing and life science.

Ventas reported strong Q3 2021 results with growth in life science, medical office, and healthcare triple net portfolios. Senior housing communities saw sustained demand and revenue growth, with average occupancy up 230 basis points sequentially. The company completed or announced $3.7 billion in strategic investments, including the acquisition of New Senior and a life science project anchored by University of California, Davis. Ventas expects a robust recovery in senior housing and aims to capture benefits from completed investments and external growth opportunities.

Ventas reported strong second quarter results, driven by significant occupancy improvements and organic net operating income growth in the Senior Housing Operating Portfolio (SHOP) segment, alongside growth in the Office segment and consistent performance in the Triple Net (NNN) segment. The company has delivered five consecutive months of occupancy growth and leads in SHOP.

Ventas reported better-than-expected financial results for Q1 2021, driven by strong performance in the Senior Housing Operating Portfolio (SHOP) and the stable performance of the Office and Triple-Net businesses. Occupancy in SHOP improved, and move-ins exceeded pre-pandemic levels in March and April.

Ventas' Q4 2020 results reflect the strength and stability of its diverse portfolio, with positive performance in the Office and Triple-Net Healthcare businesses offsetting the impact of COVID-19 on the Senior Housing Operating Portfolio (SHOP). The company prioritized health and safety and advanced strategic growth objectives, delivering results ahead of expectations despite pandemic-related challenges.

Ventas reported solid third quarter results driven by the company's diverse portfolio and stable income from their Senior Housing Operating Portfolio. Significant arrangements were made with Brookdale, and the Research and Innovation business was driven forward with a $1 billion investment. Resident move-ins exceeded move-outs in October, showing sustained improvement.

Ventas reported a net loss of $157.17 million, or $(0.42) per share, for the second quarter of 2020. Normalized FFO was $0.77 per share. The company's results were significantly impacted by the COVID-19 pandemic, particularly in its senior housing operating portfolio, but were partially offset by strong performance in its Office and Triple-Net Lease segments. Ventas took decisive actions to maintain financial strength, including reaching agreements with its two largest senior housing tenants and adjusting its cost structure.

Ventas reported strong first quarter results, exceeding expectations across all business segments, but the COVID-19 pandemic has begun to impact operations and financial condition, especially in the Seniors Housing Operating Portfolio (SHOP). The company has taken decisive actions to ensure strength and stability, including supporting tenants and operators, maintaining business operations, and increasing financial flexibility.

Ventas, Inc. reported solid enterprise results for Q4 2019, benefiting from its diverse high-quality portfolio and effective capital markets execution. While the Senior Housing business faced challenges, actions are being taken to improve performance and position the company for future success.